307 related articles for article (PubMed ID: 17439414)
1. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
[TBL] [Abstract][Full Text] [Related]
2. Bcl-XL small interfering RNA enhances sensitivity of Hepg2 hepatocellular carcinoma cells to 5-fluorouracil and hydroxycamptothecin.
Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
Acta Biochim Biophys Sin (Shanghai); 2006 Oct; 38(10):704-10. PubMed ID: 17033717
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 siRNA induced apoptosis and increased sensitivity to 5-fluorouracil and HCPT in HepG2 cells.
Feng LF; Zhong M; Lei XY; Zhu BY; Tang SS; Liao DF
J Drug Target; 2006 Jan; 14(1):21-6. PubMed ID: 16603448
[TBL] [Abstract][Full Text] [Related]
4. MiR-122 increases sensitivity of drug-resistant BEL-7402/5-FU cells to 5-fluorouracil via down-regulation of bcl-2 family proteins.
Yin J; Tang HF; Xiang Q; Yu J; Yang XY; Hu N; Lei XY
Pharmazie; 2011 Dec; 66(12):975-81. PubMed ID: 22312705
[TBL] [Abstract][Full Text] [Related]
5. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
6. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
[TBL] [Abstract][Full Text] [Related]
7. Silencing of Bcl-XL expression in human MGC-803 gastric cancer cells by siRNA.
Lei XY; Zhong M; Feng LF; Yan CY; Zhu BY; Tang SS; Liao DF
Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):555-60. PubMed ID: 16077903
[TBL] [Abstract][Full Text] [Related]
8. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
Zhu H; Guo W; Zhang L; Davis JJ; Teraishi F; Wu S; Cao X; Daniel J; Smythe WR; Fang B
Mol Cancer Ther; 2005 Mar; 4(3):451-6. PubMed ID: 15767554
[TBL] [Abstract][Full Text] [Related]
9. Enhanced sensitivity of human hepatoma cells to 5-fluorouracil by small interfering RNA targeting Bcl-2.
Kanda T; Yokosuka O; Imazeki F; Arai M; Saisho H
DNA Cell Biol; 2005 Dec; 24(12):805-9. PubMed ID: 16332177
[TBL] [Abstract][Full Text] [Related]
10. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
11. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Luo D; Cheng SC; Xie H; Xie Y
Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
[TBL] [Abstract][Full Text] [Related]
12. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
13. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of treatment with siRNA targeting Bcl-2 in combination with HCPT against transplanted H₂₂ hepatoma in mice].
Hu HH; Song HX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):892-6. PubMed ID: 24506957
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
16. Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.
Huang Z; Lei X; Zhong M; Zhu B; Tang S; Liao D
Acta Biochim Biophys Sin (Shanghai); 2007 Nov; 39(11):835-43. PubMed ID: 17989874
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Bcl-w protein in human small intestinal adenocarcinoma and effect of Bcl-w siRNA on apoptosis in intestinal adenocarcinoma HuTu-80 cells].
Guo WJ; Jin Z; Wang AY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):182-6. PubMed ID: 22780970
[TBL] [Abstract][Full Text] [Related]
18. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
[TBL] [Abstract][Full Text] [Related]
20. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis.
Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L
Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
